The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pediatrix Medical Group Inc
SWB:PDC
|
US |
|
S
|
Siemens AG
XHAN:SIE
|
DE |
|
Amaero Ltd
ASX:3DA
|
AU |
|
U
|
United Airlines Holdings Inc
F:UAL1
|
US |
|
M
|
Morgan Stanley
XMUN:DWD
|
US |
|
Xaar PLC
F:XAR
|
UK |
|
A-Zenith Home Furnishings Co Ltd
SSE:603389
|
CN |
|
M
|
Meritage Homes Corp
F:MEY
|
US |
|
Eagers Automotive Ltd
ASX:APE
|
AU |
|
Advance ZincTek Ltd
ASX:ANO
|
AU |
|
5
|
5N Plus Inc
SWB:EMB
|
CA |
|
Australis Oil & Gas Ltd
ASX:ATS
|
AU |
|
H
|
Hydrogene De France SA
PAR:HDF
|
FR |
|
B
|
Bayfirst Financial Corp
NASDAQ:BAFN
|
US |
|
F
|
F5 Inc
DUS:FFV
|
US |
|
Novatek PAO
MOEX:NVTK
|
RU |
|
LIC Housing Finance Ltd
NSE:LICHSGFIN
|
IN |
|
T
|
Tourism Holdings Ltd
ASX:THL
|
NZ |
|
Banco Santander SA
F:BSDK
|
ES |
|
O
|
Oculis Holding AG
ICEX:OCS
|
CH |
|
P
|
Paccar Inc
SWB:PAE
|
US |
|
P
|
Paccar Inc
F:PAE
|
US |
|
N
|
Nestle SA
XMUN:NESR
|
CH |
Pediatrix Medical Group Inc (PDC)’s 12-month stock price forecast through November 2027 has a consensus target of €26.39, implying 10% downside. The forecast is based on price targets from 6 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
PDC is 26.39 EUR with a low forecast of 25.23 EUR and a high forecast of 29.04 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 4 years is 5%.
Over the last 13 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 3 years is 4%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -4%. The projected CAGR for the next 3 years is 5%.
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 3 years is 7%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more